Ryaltris is a metered, fixed-dose, prescription nasal spray that delivers 665mcg of olopatadine hydrochloride, an antihistamine, and 25mcg of mometasone furoate, a corticosteroid, in each spray.

Olopatadine hydrochloride and mometasone furoate nasal spray is now available in the United States for the treatment of symptoms associated with seasonal allergic rhinitis in patients aged 12 ...

November 29, 2010 (Phoenix, Arizona) — Once-daily mometasone furoate nasal spray relieves nighttime and early morning nasal congestion in patients with seasonal allergic rhinitis, according to a ...

Each nasal spray delivers 50mcg of mometasone furoate monohydrate. The Company expects to have Nasonex 24HR Allergy available later this year. Perrigo Executive VP & President, ...

Perrigo announced that the FDA has approved mometasone furoate monohydrate, an intranasal corticosteroid nasal spray designed to treat and prevent hay fever and allergy symptoms, for over-the ...

The US Food and Drug Administration (FDA) has approved a prescription nasal spray for seasonal allergic rhinitis. Mometasone furoate monohydrate (Ryaltris) is approved for adults and pediatric ...